Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer


Study Number
4384825
Phase
N/A
Age Group
Adult
Purpose

The MRI-targeted biopsy for prostate cancer detection can be performed using one of two techniques:

1. Software-based fusion of MRI and ultrasound images (software fusion) or
2. Visually estimated MRI-informed (cognitive fusion) technique

To date, there is a lack of adequately powered RCTs directly comparing the cognitive vs fusion targeted biopsy. This randomized study will directly compare the detection rates of clinically significant prostate cancer following either the cognitive or the fusion targeted prostate biopsy in men with suspicious lesions noted on multi-parametric MRI (mp-MRI) of prostate.

Full Title

MRI-Targeted, Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer (FOCUS-PC)

ClinicalTrials.Gov ID
NCT06517901

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.